The Concept of CMREvaluating CMRManaging CMRDocumentation Center
Print this pageDecrease text sizeIncrease text size

Evaluating CMR

Clinical Tools

Many epidemiological studies have shown that chronic metabolic diseases such as hypertension ...

READ MORE

Imaging techniques

In order to properly assess the risk of type 2 diabetes and cardiovascular disease (CVD) ...

READ MORE

Assessing CVD Risk: Traditional Approaches

Cardiovascular disease (CVD) is a leading cause of disability and death.

READ MORE

Metabolic Syndrome and Type 2 Diabetes CVD Risk

The recognition of the metabolic syndrome as a risk factor for type 2 diabetes and cardiovascular ...

READ MORE

Assessing Cardiometabolic Risk

A number of groups and organizations have emphasized the importance of considering all ...

READ MORE

Document Center

A Simplified View of Victor Dzau´s Cardiovascular Continuum by Luis Miguel Ruilope, MD

A Simplified View of Victor Dzau´s Cardiovascular Continuum by Luis Miguel Ruilope, MD

More
Which factors/markers do you think will emerge as key predictors of global CMR beyond the Framingham risk score?

Which factors/markers do you think will emerge as key predictors of global CMR beyond the Framingham risk score?

More
Post-AHA 2007: Lifestyle intervention

Post-AHA 2007: Lifestyle intervention

More
Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance. Atherosclerosis 2008;197:355-62

Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance. Atherosclerosis 2008;197:355-62

More
Evidence for a greater relative accumulation of intra-abdominal adipose tissue (AT) in Japanese than Caucasian Americans

Evidence for a greater relative accumulation of intra-abdominal adipose tissue (AT) in Japanese than Caucasian Americans

More